Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€158.00
04.04.21
€75.00
04.04.22
-56.02%
05.04.22

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Good rating
ROE higher than 10% per year
skatcup 
04.04.21 80%
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€163.98
20.03.21
-
20.03.22
-46.87%
21.12.21

Could be very worthwhile Investment >20% year
Savour 
20.03.21 20%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€16.47
19.03.21
€13.00
19.03.22
-22.87%
20.02.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
19.03.21 60%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€13.38
08.03.21
€15.00
13.62%
10.03.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
08.03.21 50%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€82.98
08.03.21
-
08.03.22
-72.98%
09.03.22

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Good rating
Standard Investments for future growth
FXX 
08.03.21 60%
buy
Perrigo Co. plc

Start price
Target price
Perf. (%)
€37.00
15.02.21
-
15.02.22
5.95%
11.07.21

Could be worthwhile Investment >10% per year
Undervalued
Higher risks for its business
OldOrangeEyes 
15.02.21 50%
buy
Viatris Inc.

Start price
Target price
Perf. (%)
€15.40
15.02.21
€19.00
15.02.22
-14.92%
15.02.22

Undervalued
High dividend yield expected
leolew 
15.02.21 60%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€20.95
10.02.21
€22.00
11.75%
11.02.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
10.02.21 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€36.00
07.02.21
-
07.02.22
-80.67%
08.02.22

Probably not worthwhile Investment
High risks for its business
Few uniques
Trip 
07.02.21 50%
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€240.00
25.01.21
€350.00
25.01.22
-73.33%
26.01.22

Could be very worthwhile Investment >20% year
hanswurst00 
25.01.21 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€9.43
14.01.21
€28.00
72.92%
12.03.21

Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
gerihouse 
14.01.21 70%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€7.48
11.01.21
-
11.01.22
39.14%
15.01.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
11.01.21 70%
buy
Evotec SE

Start price
Target price
Perf. (%)
€28.90
06.01.21
€40.00
-1.18%
10.03.21

Medium risks for its business
phonebroker 
06.01.21 50%
buy
Sonic Healthcare

Start price
Target price
Perf. (%)
€20.80
31.12.20
€46.00
31.12.21
45.65%
01.01.22

Revenue growth > 30% per year expected
Rising EBIT margin expected
Undervalued
High Investments for future growth
stepdown 
31.12.20 100%
buy
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€37.79
13.12.20
-
13.12.21
-29.55%
14.12.21

Risky Investment
Maxfloh 
13.12.20 50%
buy
Invitae Corp

Start price
Target price
Perf. (%)
€48.87
11.12.20
€50.00
-14.92%
17.12.20

Traumtanz 
11.12.20 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€25.50
29.11.20
-
29.11.21
20.04%
24.03.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
FXX 
29.11.20 50%
buy
Shanghai Fosun Pharmaceutical Group Co Ltd

Start price
Target price
Perf. (%)
€3.58
28.11.20
-
28.11.21
29.47%
29.11.21

Could be worthwhile Investment >10% per year
Known brand
Maxfloh 
28.11.20 50%
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€40.23
26.11.20
€45.00
3.13%
08.12.20

Traumtanz 
26.11.20 50%
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€39.00
17.11.20
-
17.11.21
-1.74%
07.06.21

Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Little Investments for future growth
Mori8 
17.11.20 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€4.90
14.11.20
-
14.11.21
23.24%
27.11.20

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
14.11.20 50%
sell
Horizon Pharma plc

Start price
Target price
Perf. (%)
€61.15
13.11.20
-
13.11.21
30.20%
15.07.21

Could be very worthwhile Investment >20% year
Biotechhunter 
13.11.20 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€24.26
09.11.20
-
09.11.21
21.35%
14.01.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Judge 
09.11.20 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€5.20
07.11.20
€6.40
23.49%
30.11.20

Could be worthwhile Investment >10% per year
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
gerihouse 
07.11.20 50%
sell
Aphria Inc.

Start price
Target price
Perf. (%)
€4.70
05.11.20
-
05.11.21
170.32%
06.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
shadow 
05.11.20 50%